GNDs with questionable or no response to antiparkinsonian medication in most cases were Rett syndrome, Dravet syndrome (SCN1A), phosphoglycerate kinase deficiency, dystonia 16, Leigh syndrome, and Menkes disease. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.